New drug PROT-001 tested in healthy people for first time
NCT ID NCT06981299
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This early-stage study tested the safety of a new drug called PROT-001 in 102 healthy adults. Researchers gave single and multiple doses to see how the body handles the drug and how it interacts with other common medicines. Since participants were healthy, the goal was not to treat any disease but to gather essential safety and dosing information for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Pty Ltd
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.